24 Comments
author

There is no fixed relationship between those parameters.

But those all convey a similar level of risk.

Dr. P

Expand full comment

Are these results consistent across tests?: LDL-C 121; APOB 102; LDL-P 1598. I am thinking they are not. 72 yo/f who want to prevent a cardiac event.

Expand full comment
author

Gorgo,

A careful reading of my current article and all of my writing on the skeptical cardiologist on diet and exercise would inform you that

1. I constantly expound he virtues of healthy living

2. I am not on the "cholesterol causes heart disease soapbox"

3. As a preventive cardiologist I am devoted to minimizing the use of cardiovascular procedures

4. There are tens of thousands of patients who have excellent diet and lifestyle but it is not enough to prevent or reverse CAD in them.

Dr. p

Expand full comment
author

Do you have a link for this reference from 25 years ago?

Dr. P

Expand full comment
author

Dennis,

The topic of plaque regression is a complicated one. Conveying the nuance of what is going on with atherosclerotic plaque with aggressive treatment (which many consider plaque regression) was beyond the scope of this article. With high intensity statin therapy , complicated coronary imaging studies have shown regression. Some components of the plaque, however, increase (like calcium). Overall, though the components we are most worried about decline significantly.

This article summarizes current thinking in the area (https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2022/01/10/23/23/coronary-atherosclerotic-plaque-regression).

And here is a point from the link I provided.

"Statins induce plaque regression in a dose-dependent manner and proportionally to reductions in low-density lipoprotein (LDL) cholesterol. With statins, fibrous and calcified plaque volume appear to increase, while noncalcified fibrofatty and necrotic core volumes decrease. Several studies demonstrated greater plaque regression with ezetimibe compared to optimal medical therapy, but the differences were not significant. The impact of each of the PCSK9 antibody classes of drugs was evaluated with intravascular ultrasound (IVUS) in relatively large studies: one stable coronary heart disease (CHD) and the other following an ACS. The impact was modest possibly because of the impact of high-intensity statins on plaque in all patients in both studies.

Dr P

Expand full comment

"...the more effective we can be at stopping and reversing the build-up of atherosclerotic plaque; modifying plaque so that is less likely to cause MI..." I was under the assumption there was yet no way to reduce plaque; how is this accomplished?

Expand full comment
author

Christine,

Good to hear from you! Your story is the classic example of the insidious nature of CAD.

Dr. p

Expand full comment

“Due to advances in medical therapy, lifestyle and device therapy, deaths from cardiovascular disease declined by 70% between 1980 and 2009.....In the last 10 years, however, the rate of decline of ASCVD has slowed and sudden cardiac death rates have remained constant. “

The decline in rate is perhaps because many of those with ASCVD have died, but those remaining who have a sudden attack still die at the same rate. The low-hanging fruit, so to speak, have been scythed, leaving far less higher available.

Expand full comment

The point you made regarding CAD being a silent disease really should be stressed. My cholesterol was always under 200, however my elevated LDL was never addressed. I smoked for 25 years and had no known history of CAD in my family. However, I suffered an MI at age 46 and underwent a quadruple bypass. I was not overweight and exercised regularly. I later discovered my Liproprotein (a) level was "off the charts" so I was unknowingly at severe high risk for a major cardiac event. I didn't fit the "profile" of a candidate for CAD except for being a light, intermittent smoker. I worked in cardiac step down units as an RN for almost 10 years and did not know all the current facts and diagnostic tests and criteria that could have been addressed earlier in my life that might have prevented the severity of my disease at such an early age. Thanks for your knowledge and expertise in this area.

Expand full comment

Thank you for the clear explanations - very helpful!

I'm hopeful that you would consider including in your series of stories on “Profiles in Coronary Artery Disease” how a 60 year old male, in good health and no known risk factors could have a Calcium CAC score of 618. In particular, this male is not overweight, exercises regularly, eats what is typically considered a very healthy diet (according to the AHA guidelines for a healthy heart), consistently healthy blood pressure (at or below 110/70), resting pulse consistently below 50, has very good cholesterol numbers (LDL, HDL, triglycerides and relevant ratios), is not diabetic, has no know genetic dispositions (both parents lived well into their 90's, siblings are all still living and healthy) and no apparent markers for inflammation according to blood tests. Based on a few sources, it appears that one factor that could be contributing is chronic insomnia - no problems falling asleep, but waking typically occurs after 5-6 hours of sleep and trouble falling back to sleep. Sleep studies show no evidence of sleep apnea.

Any insights you could provide in your upcoming series would be greatly appreciated.

Expand full comment

A very interesting read, and easily understood and correct paths for optimum health benefits...most [we] already know, but need to be reminded. This venue is a handy reminder.

Expand full comment

Thank you🙏. Really appreciate the commentary. Your writing helped me advocate for further investigation (for myself) with CAC and advanced lipids.

Expand full comment

I actually understood all that! Thank you so much for taking the time to write such an edifying post for us newbies to the ins-and-outs of heart disease!

Expand full comment